Synthetic Cathinones: A New Public Health Problem

New psychoactive substances (NPS) have completely modified the drug scene and the current landscape of addiction. Synthetic substances, such as substituted or synthetic cathinones, also known as « legal highs », are often produced and used to mimic the effects of controlled drugs such as cocaine, methylenedioxymethamphetamine (MDMA, ecstasy), and methamphetamine. The overwhelming majority of synthetic cathinones are produced in China and South East Asian countries. The Internet has emerged as the new marketplace for NPS, playing a major role in providing information on acquisition, synthesis, extraction, identification, and substance use. All these compounds are intentionally mislabeled and sold on-line under slang terms such as bath salts, plant food, plant feeders and research chemicals. They are sometimes labeled « not for human use » or « not tested for hazards or toxicity ». The rapid spread of NPS forces member countries of the European Union to adapt their response to the potential new dangers that may cause. To date, not only health actors but also the general public need to be clearly informed and aware of dangers resulting from NPS spread and use. Here, we review the major clinical effects of synthetic cathinones to highlight their impact on public health. A literature search was conducted from 2009 to 2014 based on PubMed, Google Scholar, Erowid, and governmental websites, using the following keywords alone or in combination: “new psychoactive substances”, “synthetic cathinones”, “substituted cathinones”, “mephedrone”, “methylone”, “MDPV”, “4-MEC”, “addiction”, and “substance use disorder”.

[1]  M. Forster,et al.  Locomotor stimulant and discriminative stimulus effects of ‘bath salt’ cathinones , 2013, Behavioural pharmacology.

[2]  M. Liechti,et al.  Pharmacological characterization of designer cathinones in vitro , 2013, British journal of pharmacology.

[3]  N. Sadeg,et al.  Methcathinone: a new postindustrial drug. , 2005, Forensic science international.

[4]  P. Dargan,et al.  The European Drug Emergencies Network (Euro-DEN) , 2014, Clinical toxicology.

[5]  J. Cisek,et al.  Methcathinone: a Russian designer amphetamine infiltrates the rural midwest. , 1993, Annals of emergency medicine.

[6]  T. Penders,et al.  Intoxication Delirium following Use of Synthetic Cathinone Derivatives , 2012, The American journal of drug and alcohol abuse.

[7]  F. Schifano,et al.  Suspected and Confirmed Fatalities Associated With Mephedrone (4-Methylmethcathinone, “Meow Meow”) in the United Kingdom , 2012, Journal of clinical psychopharmacology.

[8]  J. Camarasa,et al.  Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone , 2012, British journal of pharmacology.

[9]  G. Reisfield,et al.  Psychoactive "bath salts" intoxication with methylenedioxypyrovalerone. , 2012, The American journal of medicine.

[10]  M. St-Onge,et al.  Seizures and Hyponatremia Related to Ethcathinone and Methylone Poisoning , 2011, Journal of Medical Toxicology.

[11]  T. Dickerson,et al.  The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: Self-administration and locomotor activity in rats , 2013, Neuropharmacology.

[12]  Kurt R. Lehner,et al.  Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV), a Principal Constituent of Psychoactive ‘Bath Salts’ Products , 2013, Neuropsychopharmacology.

[13]  Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order. , 2011, Federal register.

[14]  C. R. Clark,et al.  Synthetic cathinones: "a khat and mouse game". , 2014, Toxicology letters.

[15]  J. Zawilska,et al.  Designer cathinones--an emerging class of novel recreational drugs. , 2013, Forensic science international.

[16]  M. Coppola,et al.  3,4-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online. , 2012, Toxicology letters.

[17]  American Association of Poison Control Centers , 1966 .

[18]  Derrick J Pounder,et al.  Mephedrone (4-methylmethcathinone)-related deaths. , 2011, Journal of analytical toxicology.

[19]  A. D. Krikorian,et al.  Kat and its use: an historical perspective. , 1984, Journal of ethnopharmacology.

[20]  Mark Mitchelson,et al.  Mephedrone toxicity in a Scottish emergency department , 2010, Emergency Medicine Journal.

[21]  P. Dargan,et al.  Using poisons information service data to assess the acute harms associated with novel psychoactive substances. , 2014, Drug testing and analysis.

[22]  Laurent Karila,et al.  New designer drugs (synthetic cannabinoids and synthetic cathinones): review of literature. , 2014, Current pharmaceutical design.

[23]  P. Dargan,et al.  Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change. , 2010, QJM : monthly journal of the Association of Physicians.

[24]  J. Ramsey,et al.  Energy-1 (‘NRG-1’): don't believe what the newspapers say about it being legal , 2011, Emergency Medicine Journal.

[25]  M. Zloh,et al.  An analysis of the 'legal high' mephedrone. , 2010, Bioorganic & medicinal chemistry letters.

[26]  Cinzia Pezzolesi,et al.  Identifying emerging trends in recreational drug use; outcomes from the Psychonaut Web Mapping Project , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[27]  P. Griffiths,et al.  Khat use and monitoring drug use in Europe: the current situation and issues for the future. , 2010, Journal of ethnopharmacology.

[28]  Henry A Spiller,et al.  Clinical experience with and analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in the United States , 2011, Clinical toxicology.

[29]  P. Dalal,et al.  Bath salt intoxication causing acute kidney injury requiring hemodialysis , 2012, Hemodialysis international. International Symposium on Home Hemodialysis.

[30]  M. Olive,et al.  Potent rewarding and reinforcing effects of the synthetic cathinone 3,4‐methylenedioxypyrovalerone (MDPV) , 2014, Addiction biology.

[31]  Lewis S. Nelson,et al.  The Toxicology of Bath Salts: A Review of Synthetic Cathinones , 2011, Journal of Medical Toxicology.

[32]  R. Spears,et al.  Clinical characteristics of mephedrone toxicity reported to the UK National Poisons Information Service , 2010, Emergency Medicine Journal.

[33]  Belinda Weimer,et al.  National Forensic Laboratory Information System: Midyear report 2012 , 2013 .

[34]  M. Meyer,et al.  Metabolism of designer drugs of abuse: an updated review. , 2010, Current drug metabolism.

[35]  Ana Margarida Araújo,et al.  Raising awareness of new psychoactive substances: chemical analysis and in vitro toxicity screening of ‘legal high’ packages containing synthetic cathinones , 2014, Archives of Toxicology.

[36]  Frank T Peters,et al.  Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography–mass spectrometry , 2010, Analytical and bioanalytical chemistry.

[37]  L. Karila,et al.  GHB and synthetic cathinones: clinical effects and potential consequences. , 2011, Drug testing and analysis.

[38]  C. Escher,et al.  [Mephedrone--Internet drug which seems to have come and stay. Fatal cases in Sweden have drawn attention to previously unknown substance]. , 2009, Lakartidningen.

[39]  R. Glennon,et al.  Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of “bath salts,” produce opposite effects at the human dopamine transporter , 2013, Psychopharmacology.

[40]  C. Rosenbaum,et al.  Here Today, Gone Tomorrow…and Back Again? A Review of Herbal Marijuana Alternatives (K2, Spice), Synthetic Cathinones (Bath Salts), Kratom, Salvia divinorum, Methoxetamine, and Piperazines , 2012, Journal of Medical Toxicology.

[41]  L. King,et al.  A brief history of 'new psychoactive substances'. , 2011, Drug testing and analysis.

[42]  G. Hanson,et al.  Bath salts and synthetic cathinones: an emerging designer drug phenomenon. , 2014, Life sciences.

[43]  F. Hickson,et al.  The Chemsex study: drug use in sexual settings among gay and bisexual men in Lambeth, Southwark and Lewisham , 2014 .

[44]  R. Glennon,et al.  Cathinone: An Investigation of Several N-Alkyl and Methylenedioxy-Substituted Analogs , 1997, Pharmacology Biochemistry and Behavior.

[45]  B. Levine,et al.  Multiple-drug toxicity caused by the coadministration of 4-methylmethcathinone (mephedrone) and heroin. , 2010, Journal of analytical toxicology.

[46]  A. Blank The American Association of Poison Control Centers. , 1960, Clinical toxicology.

[47]  R. Gerona,et al.  Psychosis from a Bath Salt Product Containing Flephedrone and MDPV with Serum, Urine, and Product Quantification , 2012, Journal of Medical Toxicology.

[48]  I. McGregor,et al.  Mephedrone (4‐methylmethcathinone, ‘meow’): acute behavioural effects and distribution of Fos expression in adolescent rats , 2012, Addiction biology.

[49]  Kurt R. Lehner,et al.  Psychoactive "bath salts": not so soothing. , 2013, European journal of pharmacology.

[50]  K. Hashimoto,et al.  Combined intoxication with methylone and 5-MeO-MIPT , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[51]  P. Dargan,et al.  Mephedrone (4-methylmethcathinone): What is new in our understanding of its use and toxicity , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[52]  Iain M McIntyre,et al.  Acute methylone intoxication in an accidental drowning--a case report. , 2013, Forensic science international.

[53]  P. Dargan,et al.  Limited use of novel psychoactive substances in South London nightclubs. , 2012, QJM : monthly journal of the Association of Physicians.

[54]  Matt Anderson,et al.  European Monitoring Centre for Drugs and Drug Addiction , 2014 .

[55]  Cassie L. Boggs,et al.  Methylenedioxypyrovalerone (“Bath Salts”),Related Death: Case Report and Review of the Literature , , 2013, Journal of forensic sciences.

[56]  Maria João Valente,et al.  Khat and synthetic cathinones: a review , 2013, Archives of Toxicology.

[57]  K. Houseknecht,et al.  Contrasting effects of d-methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats. , 2012, Drug and alcohol dependence.

[58]  M. Bossong,et al.  Methylone and mCPP, two new drugs of abuse? , 2005, Addiction biology.